PROTHENA CORP PUBLIC LTD CO
Advancing antibody-based therapies for neurodegenerative and rare amyloid diseases.
PRTA | NDAQ
Overview
Corporate Details
- ISIN(s):
- USG728001086 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 77 SIR JOHN ROGERSON'S QUAY, BLOCK C, DUBLIN 2
- Website:
- https://www.prothena.com/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Prothena Corporation plc is a late-stage clinical biotechnology company specializing in neuroscience. The company leverages its deep expertise in protein dysregulation and the biology of misfolded proteins to discover and develop a diverse pipeline of novel therapeutics. Its scientific approach focuses on advancing antibody-based investigational therapies designed to provide clinically meaningful benefits for patients with neurodegenerative and rare peripheral amyloid diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all PROTHENA CORP PUBLIC LTD CO filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for PROTHENA CORP PUBLIC LTD CO
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for PROTHENA CORP PUBLIC LTD CO via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
